雜志介紹

Experimental And Molecular Pathology雜志介紹

《Experimental And Molecular Pathology》是一本以English為主的未開放獲取國際優秀期刊，中文名稱實驗和分子病理學，本刊主要出版、報道醫學-PATHOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.8，最新CiteScore 指數為8.9。

本刊近期中國學者發表的論文主要有：

• Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma

  Author: Zhaoting Yang, Chengye Zhang, Ying Feng, Wenbo Qi, Yan Cui, Yanhua Xuan

• Effects of GST null genotypes on individual susceptibility to leukemia: A meta-analysis

  Author: Jun Wang, Depei Wu, Aining Sun

• Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1

  Author: Jinliang Li, Yuxi Qi

• Baicalin protects human retinal pigment epithelial cell lines against high glucose-induced cell injury by up-regulation of microRNA-145

  Author: Chunhua Dai, Shanhao Jiang, Cuiying Chu, Meng Xin, Xiufen Song, Bojun Zhao

英文介紹

Experimental And Molecular Pathology雜志英文介紹

Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature's most jealously guarded secrets on the pathologic basis of disease.

Research Areas include: Stem cells; Neoangiogenesis; Molecular diagnostics; Polymerase chain reaction; In situ hybridization; DNA sequencing; Cell receptors; Carcinogenesis; Pathobiology of neoplasia; Complex infectious diseases; Transplantation; Cytokines; Flow cytomeric analysis; Inflammation; Cellular injury; Immunology and hypersensitivity; Athersclerosis.